1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Patient characteristics
Total (n = 136)Good Outcome (n = 29)Poor Outcome (n = 107)P Valuea
Age (mean) (SD)80.6 (10.1)79.5 (13.2)81.0 (9.2).585
Female (No.) (%)90 (66.2)20 (69.0)70 (65.4).827
Diabetes (No.) (%)34 (25.0)5 (17.2)29 (27.1).340
Hypertension (No.) (%)102 (75.0)21 (72.4)81 (75.7).809
Arrhythmia (No.) (%)84 (61.8)19 (65.5)65 (60.7).674
Coronary heart disease (No.) (%)41 (30.1)8 (27.6)33 (30.8).822
Hypercholesterolemia (No.) (%)41 (30.1)8 (27.6)33 (30.8).822
Premorbid mRS (No.) (%).719
    3111 (81.6)23 (79.3)88 (82.2)
    425 (18.4)6 (20.7)19 (17.8)
Baseline NIHSS (median) (IQR)18 (15–22)15 (12–19)19 (15–23).009
ASPECTS (median) (IQR)9 (8–10)10 (9–10)9 (8–10).051
Intravenous thrombolysis (No.) (%)61 (44.9)13 (44.8)48 (44.9)1.000
Onset-to-groin (median) (IQR)240 (180–344)232 (182–280)247 (180–357).250
Groin-to-TICI (median) (IQR)75 (41–108)63 (32–97)77 (46–117).142
Occlusion site (No.) (%)
    ICA31 (22.8)2 (6.9)29 (27.1).024
    M178 (57.4)15 (51.7)63 (58.9).530
    M230 (22.1)12 (41.4)18 (16.8).010
TICI 2b–3103 (75.7)27 (93.1)76 (71.0).014
  • Note:—IQR indicates interquartile range.
  • ↵a Comparison between patients with good and poor outcomes.